1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 CIS PROLINE - PRO 48 Lubienski, M.J. Bycroft, M. Freund, S.M.V. Fersht, A.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 33 8866 8877 10.1021/bi00196a003 8043574 Three-dimensional solution structure and 13C assignments of barstar using nuclear magnetic resonance spectroscopy. 1994 NE Trends Biochem.Sci. TBSCDB 0946 0968-0004 14 450 Barnase and Barstar: Two Small Proteins to Fold and Fit Together 1989 10.2210/pdb1bta/pdb pdb_00001bta 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 10221.543 BARSTAR 1 man polymer no no KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE GCDITIILS KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE GCDITIILS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Bacillus sample 1390 Bacillus amyloliquefaciens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-07-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1994-05-09 REL 1 BRUNGER refinement X-PLOR LYS 1 n 1 LYS 1 A LYS 2 n 2 LYS 2 A ALA 3 n 3 ALA 3 A VAL 4 n 4 VAL 4 A ILE 5 n 5 ILE 5 A ASN 6 n 6 ASN 6 A GLY 7 n 7 GLY 7 A GLU 8 n 8 GLU 8 A GLN 9 n 9 GLN 9 A ILE 10 n 10 ILE 10 A ARG 11 n 11 ARG 11 A SER 12 n 12 SER 12 A ILE 13 n 13 ILE 13 A SER 14 n 14 SER 14 A ASP 15 n 15 ASP 15 A LEU 16 n 16 LEU 16 A HIS 17 n 17 HIS 17 A GLN 18 n 18 GLN 18 A THR 19 n 19 THR 19 A LEU 20 n 20 LEU 20 A LYS 21 n 21 LYS 21 A LYS 22 n 22 LYS 22 A GLU 23 n 23 GLU 23 A LEU 24 n 24 LEU 24 A ALA 25 n 25 ALA 25 A LEU 26 n 26 LEU 26 A PRO 27 n 27 PRO 27 A GLU 28 n 28 GLU 28 A TYR 29 n 29 TYR 29 A TYR 30 n 30 TYR 30 A GLY 31 n 31 GLY 31 A GLU 32 n 32 GLU 32 A ASN 33 n 33 ASN 33 A LEU 34 n 34 LEU 34 A ASP 35 n 35 ASP 35 A ALA 36 n 36 ALA 36 A LEU 37 n 37 LEU 37 A TRP 38 n 38 TRP 38 A ASP 39 n 39 ASP 39 A CYS 40 n 40 CYS 40 A LEU 41 n 41 LEU 41 A THR 42 n 42 THR 42 A GLY 43 n 43 GLY 43 A TRP 44 n 44 TRP 44 A VAL 45 n 45 VAL 45 A GLU 46 n 46 GLU 46 A TYR 47 n 47 TYR 47 A PRO 48 n 48 PRO 48 A LEU 49 n 49 LEU 49 A VAL 50 n 50 VAL 50 A LEU 51 n 51 LEU 51 A GLU 52 n 52 GLU 52 A TRP 53 n 53 TRP 53 A ARG 54 n 54 ARG 54 A GLN 55 n 55 GLN 55 A PHE 56 n 56 PHE 56 A GLU 57 n 57 GLU 57 A GLN 58 n 58 GLN 58 A SER 59 n 59 SER 59 A LYS 60 n 60 LYS 60 A GLN 61 n 61 GLN 61 A LEU 62 n 62 LEU 62 A THR 63 n 63 THR 63 A GLU 64 n 64 GLU 64 A ASN 65 n 65 ASN 65 A GLY 66 n 66 GLY 66 A ALA 67 n 67 ALA 67 A GLU 68 n 68 GLU 68 A SER 69 n 69 SER 69 A VAL 70 n 70 VAL 70 A LEU 71 n 71 LEU 71 A GLN 72 n 72 GLN 72 A VAL 73 n 73 VAL 73 A PHE 74 n 74 PHE 74 A ARG 75 n 75 ARG 75 A GLU 76 n 76 GLU 76 A ALA 77 n 77 ALA 77 A LYS 78 n 78 LYS 78 A ALA 79 n 79 ALA 79 A GLU 80 n 80 GLU 80 A GLY 81 n 81 GLY 81 A CYS 82 n 82 CYS 82 A ASP 83 n 83 ASP 83 A ILE 84 n 84 ILE 84 A THR 85 n 85 THR 85 A ILE 86 n 86 ILE 86 A ILE 87 n 87 ILE 87 A LEU 88 n 88 LEU 88 A SER 89 n 89 SER 89 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 11 0.173 SIDE CHAIN 1 A ARG 54 0.309 SIDE CHAIN 1 A ARG 75 0.108 SIDE CHAIN 1 A PRO 27 -57.36 -179.66 1 A TYR 30 -38.41 105.85 1 A GLU 32 50.07 3.60 1 A TRP 44 177.13 -66.63 1 A LEU 62 -33.51 -32.03 1 A GLU 64 -12.37 106.99 1 A ASN 65 73.69 32.13 1 A ASP 83 -109.29 65.33 1 A THR 85 -52.92 98.90 model building X-PLOR refinement X-PLOR phasing X-PLOR THREE-DIMENSIONAL SOLUTION STRUCTURE AND 13C ASSIGNMENTS OF BARSTAR USING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1 Y N A SER 14 A SER 14 HELX_P A ALA 25 A ALA 25 1 H1 12 A ASN 33 A ASN 33 HELX_P A GLY 43 A GLY 43 1 H2 11 A PHE 56 A PHE 56 HELX_P A THR 63 A THR 63 1 H3 8 A GLU 68 A GLU 68 HELX_P A GLY 81 A GLY 81 1 H4 14 RIBONUCLEASE INHIBITOR RIBONUCLEASE INHIBITOR A TYR 47 A TYR 47 1 A PRO 48 A PRO 48 0.92 BARS_BACAM UNP 1 1 P11540 KKAVINGEQIRSISDLHQTLKKELALPEYYGENLDALWDCLTGWVEYPLVLEWRQFEQSKQLTENGAESVLQVFREAKAE GCDITIILS 1 89 1BTA 1 89 P11540 A 1 1 89 3 parallel parallel A LYS 1 A LYS 1 A ASN 6 A ASN 6 A LEU 49 A LEU 49 A ARG 54 A ARG 54 A ASP 83 A ASP 83 A SER 89 A SER 89 1 P 1